Crinetics Pharmaceuticals Inc
CRNX
Company Profile
Business description
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Contact
6055 Lusk Boulevard
San DiegoCA92121
USAT: +1 858 450-6464
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
437
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,743.60 | 30.00 | -0.34% |
CAC 40 | 7,691.55 | 134.24 | 1.78% |
DAX 40 | 24,033.22 | 383.92 | 1.62% |
Dow JONES (US) | 43,819.27 | 432.43 | 1.00% |
FTSE 100 | 8,798.91 | 63.31 | 0.72% |
HKSE | 24,284.15 | 41.25 | -0.17% |
NASDAQ | 20,273.46 | 105.55 | 0.52% |
Nikkei 225 | 40,150.79 | 566.21 | 1.43% |
NZX 50 Index | 12,583.59 | 103.54 | 0.83% |
S&P 500 | 6,173.07 | 32.05 | 0.52% |
S&P/ASX 200 | 8,514.20 | 36.60 | -0.43% |
SSE Composite Index | 3,424.23 | 24.23 | -0.70% |